Research

- 10.282026
  
  Anti-Commercial Bribery in the Pharmaceutical Industry Should Not Stop at Sales: Compliance Insights from the Xinbang Pharmaceutical and Subsidiary Corporate Bribery Case
  
  see more
- 10.272026
  
  Observations and Communication in the Notarization of Voluntary Guardianship Agreements: From "Why Not Turn to Relatives?" to "How to Put Trust into Practice"
  
  see more
- 10.222026
  
  How Pharmaceutical Promotion Commissions Are Used for Bribery: Compliance Risks in Third-Party Promotion Through the Lens of a Criminal Judgment
  
  see more
- 10.202026
  
  Pet Law Research | How is Liability Assessed When Pets Cause Bodily Injury or Property Damage?
  
  see more
- 10.132026
  
  Subject Injury in Drug Clinical Trials: How to Determine Causality with the Trial?
  
  see more
- 10.122026
  
  Wealth Inheritance & Pitfall Avoidance Series, Part 3 | Chapter 2: The Wealth Dilemma of Ordinary People: Why Is Money So Hard to Earn and So Easy to Lose? (Part 1)
  
  see more